Replies to post #212792 on Amarin Corp Plc (AMRN)

[Bio_pete]

When you are one of those 3.5% then the number is very large. If you could reduce your risk of one of these CV events how much is it worth to you?

[jessellivermore]

Will Lar...

Quote..."Thanks for sharing the calculation. Interesting. The numbers used in the math are for the primary events which I thought are non-fatal events. The secondary events include cv death and others and the risk % is even smaller, e.g., 3.5%?"

Once again you demonstrate why you should be listening and not educating...

Obviously you do not understand what is meant by primary and secondary events...The distinction has nothing to do with severity of the event...Primary events are events seen in patients who have no documented history of CVD...That is have not had a previous event like an MI, an ischemic stroke...or even Angina requiring hospitalization...A primary event can be a fatal MI...Secondary events are those occurring in patients that do have a documented history of CVD,,,such as a previous heart attack, stroke or a coronary intervention..From a trial standpoint events are much more commom in secondary patients because they have known CVD...Events are less common in primary prevention patients...

":>) JL

[Atom0aks]

Atom - Thanks for sharing the calculation. Interesting. The numbers used in the math are for the primary events which I thought are non-fatal events. The secondary events include cv death and others and the risk % is even smaller, e.g., 3.5%?

See this post 212898 and let me know if that answers your question.

In any case, the % number is small, but multiply % with Vascepa target population size can yield hundred thousands patients in US, which easily beat any cancer patient population size. It's not necessarily death, but life threatening condition for all.

For sure!